Lupin intros clobetasol propionate lotion, cream
Lupin has introduced two additions to its topical generics portfolio. The company launched its generic of Galderma Labs’ Clobex Lotion (clobetasol propionate lotion, 0.05%) and Fougera Pharmaceuticals’ Temovate Cream (clobetasol propionate cream, 0.05%).
Lupin’s generic Clobex Lotion and its generic Temovate Cream are indicated to relieve inflammatory and pruritic manifestations of dermatoses that respond to corticosteroids.
Clobetasol propionate lotion had U.S. sales of $12.6 million for the 12 months ended December 2017 and the cream had U.S. sales of $135 million for the 12 months ended October 2017, according to IQVIA data.
Lupin’s generic Clobex Lotion and its generic Temovate Cream are indicated to relieve inflammatory and pruritic manifestations of dermatoses that respond to corticosteroids.
Clobetasol propionate lotion had U.S. sales of $12.6 million for the 12 months ended December 2017 and the cream had U.S. sales of $135 million for the 12 months ended October 2017, according to IQVIA data.